What is PNC-27 used for?
PNC-27 is most commonly used for cancer-research contexts under medical oversight; educational reference, pre-clinical only; compassionate-use research scenarios. Membranolytic peptide that selectively kills cancer cells expressing HDM-2 (oncoprotein) on the membrane surface. Pre-clinical anti-cancer research compound. Human evidence for PNC-27 is limited, so these are the goals people pursue with it, not guaranteed outcomes.
What people use PNC-27 for
- Cancer-research contexts under medical oversight
- Educational reference, pre-clinical only
- Compassionate-use research scenarios
References
- PNC-27, anticancer peptide that selectively kills HDM-2-expressing cancer cells — Michl J et al., Anticancer Res, 2006
- Anti-Cancer Peptide PNC-27 Kills Cancer Cells by Unique Interactions with Plasma Membrane-Bound hdm-2 and with Mitochondrial Membranes Causing Mitochondrial Disruption — Krzesaj P et al., Annals of Clinical and Laboratory Science, 2024
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on PNC-27
Last updated 2026-06-15.